David A Six
12PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Dec 23, 2025
Exploring the activity of a novel orally bioavailable β-lactam-β-lactamase inhibitor combination, ceftibuten-ledaborbactam, against Enterobacterales-carrying blaOXA-48.Maria F Mojica, Elise T Zeiser, Scott A Becka
|Sep 12, 2025
Burkholderia pseudomallei PenI β-lactamase and variants are potently inhibited by taniborbactam.Maria F Mojica, Scott A Becka, Mitchell Edwards
|Jun 12, 2025
Structure and mechanism of taniborbactam inhibition of the cefepime-hydrolyzing, partial R2-loop deletion Pseudomonas-derived cephalosporinase variant PDC-88.Andrew R Mack, Vijay Kumar, Christopher R Bethel
|Apr 01, 2025
Spectrum of cefepime-taniborbactam coverage against 190 β-lactamases defined in engineered isogenic Escherichia coli strains.Tsuyoshi Uehara, Cassandra L Chatwin, Brittany Miller
|Oct 30, 2024
ARGONAUT-IV: susceptibility of carbapenemase-producing Klebsiella pneumoniae to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten.Michael R Jacobs, Caryn E Good, Ayman M Abdelhamed
|Sep 24, 2024
Cefepime-taniborbactam demonstrates potent in vitro activity vs Enterobacterales with blaOXA-48.Maria F Mojica, Elise T Zeiser, Scott A Becka
Pageof 2
Frequent Collaborators
7 joint publications
Krisztina M Papp-Wallace
6 joint publications
Tsuyoshi Uehara
5 joint publications
Robert A Bonomo
5 joint publications
Greg Moeck
4 joint publications
Maria F Mojica
3 joint publications
Andrew R Mack
2 joint publications
Daniel D Rhoads
2 joint publications
Denis M Daigle
2 joint publications
Michael R Jacobs
2 joint publications
Robin Patel
